Westlake Dermatology & Cosmetic Surgery

CLIA Laboratory Citation Details

2
Total Citations
12
Total Deficiencyies
5
Unique D-Tags
CMS Certification Number 45D2221746
Address 2201 Onion Creek Parkway, Austin, TX, 78747
City Austin
State TX
Zip Code78747
Phone(512) 649-3376

Citation History (2 surveys)

Survey - February 8, 2024

Survey Type: Standard

Survey Event ID: CJQY11

Deficiency Tags: D0000 D1001 D0000 D1001

Summary:

Summary Statement of Deficiencies D0000 The laboratory was surveyed and found to be in compliance with the Conditions of the CLIA regulations found at 42 CFR 493.1 through 493.1780, and recertification is recommended. D1001 CERTIFICATE OF WAIVER TESTS CFR(s): 493.15(e) Laboratories eligible for a certificate of waiver must-- (1) Follow manufacturers' instructions for performing the test; and (2) Meet the requirements in subpart B, Certificate of Waiver, of this part. This STANDARD is not met as evidenced by: Based on observation, interview, review of manufacturer's instructions, and patient testing logs, the laboratory failed to provide the instructions for the various urine pregnancy tests performed in the dermatologist office for two of two test kits observed and performed on February 8, 2024. Findings follow. 1. During a tour of the laboratory on February 8, 2024 at 1120 hours, the surveyor observed the open test kit in the laboratory was the Medline hCG Pregnancy Test Cassette, Lot # W00130918, Exp 9/11/2025, with a sticker showing it was opened the same day, 02/08/2024. The package insert for the Medline test cassettes was requested on February 8, 2024 at 1123 hours but could not be found. 2. Interview with the histotechnologist on February 8, 2024 at 1125 hours acknowledged the laboratory gets different kits in depending on what's cheapest and confirmed the only instructions available was a quick guide on the inside lid of the Medline test cassettes box and instructions at the bottom of the pregnancy log for the Henry Schein dipstick. 3. During a tour of the laboratory on February 8, 2024 at 1127 hours surveyor found the Medline hCG Pregnancy Test Cassette package insert in the trash can. 4. Interview with the medical assistant on February 8, 2024 at 1130 hours acknowledged she just opened the new kit this morning and ran external controls, uses 3 drops of urine and sets on the counter and comes back and reads when she sees the control line in about 5 minutes, and does Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- not use a timer. 5. Review of manufacturer's instructions for the Medline hCG Pregnancy Test Cassette under Directions for Use stated, "Holding a sample dropper vertically, add exactly four drops of the urine specimen to the sample well. Read results in 3-5 minutes. Do not read results after 5 minutes." 6. During a tour of the laboratory on February 8, 2024 at 1133 hours the surveyor found 2 Henry Schein One Step + cassettes in the trash can. 7. Interview with the medical assistant on February 8, 2024 at 1135 hours confirmed she used the Henry Schein cassettes on two patients that morning from the last kit. 8. Review of the Pregnancy Test Log on February 8, 2024 at 1135 hours showed two patients had been tested that morning, on 02/08/2024, no identifier other than Date of Birth noted on form, unable to list. 9. Review of the Henry Schein One Step + hCG Urine Cassette Test Instructional Insert (obtained by an outside source) under Directions for Use stated, "2. Place the test cassette on a clean and level surface. Hold the pipette vertically and transfer 3 full drops of urine (approximately 100 uL) to the specimen well of the test cassette, and then start the timer. 3. Wait for the red line(s) to appear. Read the result at 3-4 minutes. Do not interpret results after the appropriate read time. It is important that the background is clear before the result is read." 10. Interview with the histotechnologist on February 8, 2024 at 1140 hours confirmed the pregnancy test was used for their Accutane patients. 11. Review of the Pregnancy Test Log from 07/25/2023 - 02/08/2024 showed 47 patients had been tested. The package insert contains the full instructions for performing the pregnancy test, and the instructions vary by manufacturer and method - cassettes and strips. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - May 24, 2022

Survey Type: Standard

Survey Event ID: DV7E11

Deficiency Tags: D0000 D5413 D5429 D5473 D0000 D5413 D5429 D5473

Summary:

Summary Statement of Deficiencies D0000 The facility was found to be in compliance with applicable Conditions of Participation in the CLIA program, and recertification is recommended. D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (1) Water quality. (2) Temperature. (3) Humidity. (4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Based on review of temperature records and interview, the laboratory failed to provide documentation that the daily temperature and humidity was monitored on 11 out of 54 days reviewed. Findings follow. A. Review of the on-line Compliance Portal from 11 /08/2021 - 05/23/2022 showed on the daily Lab Temperature Log the Temperature and Humidity were not documented on the following dates of patient testing: 1. 11/17 /2021 2. 11/22/2021 3. 11/23/2021 4. 12/28/2021 5. 01/05/2022 6. 02/07/2022 7. 02/14 /2022 8. 02/16/2022 9. 02/21/2022 10. 02/28/2022 11. 03/02/2022 B. Interview with the histotechnologist on May 24, 2022 at 1500 hours in the Mohs laboratory confirmed the findings. D5429 MAINTENANCE AND FUNCTION CHECKS CFR(s): 493.1254(a)(1) For unmodified manufacturer's equipment, instruments, or test systems, the laboratory must perform and document maintenance as defined by the manufacturer and with at Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- least the frequency specified by the manufacturer. This STANDARD is not met as evidenced by: Based on review of daily maintenance and interview, the laboratory failed to provide documentation that the daily maintenance on the Avantik QS12 Cryostat used in Mohs testing was performed on 11 out of 54 days reviewed. Findings follow. A. Review of the on-line Compliance Portal from 11/08/2021 - 05/23/2022 showed daily maintenance for [Cryostat] Temperature Remove section waste with a cold brush Clean debris from cryostat and clean window with 100% alcohol Remove section waste tray and empty Defrosting cryostat No unlabeled secondary containers were not documented on the following dates of patient testing: 1. 11/17/2021 2. 11/22/2021 3. 11/23/2021 4. 12/28/2021 5. 01/05/2022 6. 02/07/2022 7. 02/14/2022 8. 02/16/2022 9. 02/21/2022 10. 02/28/2022 11. 03/02/2022 B. Interview with the histotechnologist on May 24, 2022 at 1430 hours in the Mohs laboratory confirmed the findings. D5473 CONTROL PROCEDURES CFR(s): 493.1256(e)(2)(g) (e) For reagent, media, and supply checks, the laboratory must do the following: (e) (2) Each day of use (unless otherwise specified in this subpart), test staining materials for intended reactivity to ensure predictable staining characteristics. Control materials for both positive and negative reactivity must be included, as appropriate. (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on review of the quality control records, patient testing logs, and interview, the laboratory failed to ensure the Hematoxylin and Eosin (H&E) stain used in Mohs was stained predictably for 13 out of 54 days of patient testing reviewed. Findings follow. A. Review of the laboratory's on-line Compliance Portal under Pathologist H&E where the intended reactivity of the H&E stain for nuclear stain detail and cytoplasmic stain detail was documented showed from 11/08/2021 - 05/23/2022 there were 13 days of patient testing with no documentation of controls: 1. 11/09/2021 2. 11 /15/2021 3. 11/17/2021 4. 11/22/2021 5. 11/23/2021 6. 11/24/2021 7. 11/29/2021 8. 12 /01/2021 9. 12/13/2021 10. 01/19/2022 11. 02/14/2022 12. 02/21/2022 13. 03/02/2022 B. Review of the patient testing logs showed 52 Mohs cases were reported on those dates. The following shows the number of cases each day of testing: 1. 11/09/2021: 4 2. 11/15/2021: 4 3. 11/17/2021: 4 4. 11/22/2021:3 5. 11/23/2021: 4 6. 11/24/2021: 2 7. 11/29/2021: 3 8. 12/01/2021: 4 9. 12/13/2021: 5 10. 01/19/2022: 4 11. 02/14/2022: 4 12. 02/21/2022: 7 13. 03/02/2022: 4 C. Interview with the histotechnologist on May 24, 2022 at 1400 hours in the Mohs laboratory confirmed the findings. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access